Showing 1 - 10 of 158
pharmaceutical firms in Mexico. Results show that the influence of human resource management is contingent on the knowledge flows and …
Persistent link: https://www.econbiz.de/10010712046
developing countries. But why this is so? Based on evidence from the pharmaceutical industry in Mexico, this paper identifies …
Persistent link: https://www.econbiz.de/10010712332
The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector...
Persistent link: https://www.econbiz.de/10010712051
paper critically addresses some of these issues with particular reference to Mexico. The latter case equally illustrates …
Persistent link: https://www.econbiz.de/10010712249
During the past 20 years, the world pharmaceutical industry has experienced a dramatic increase in R&D intensity. We apply and extend a model developed by Grabowski and Vernon (2000) with a pooled data sample of the 15 publicly listed Japanese drug firms for the period 1987 to 1998. As in the...
Persistent link: https://www.econbiz.de/10010856449
Translating R&D and inventive efforts into a market product is characterized by significant financial skills, and the ability to overcome technical and instititonal barriers. Research into and translation of new technologies such as biotechnology products to the market requires even greater...
Persistent link: https://www.econbiz.de/10010712041
This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade...
Persistent link: https://www.econbiz.de/10010712160
Along with the rapid growth of nanoscience research and the wide application of nanotechnology into various industrial fields, the innovation patterns and co-evolutionary natures of multiple nano industrial sectors has drawn much attention from scholars. Based on a continuously updated...
Persistent link: https://www.econbiz.de/10010712306
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
This paper asks: what can governments of new member states do to encourage MNEs to invest in R&D? There are two types of MNE R&D. Innovation can be undertaken in order to adapt its existing products and services to local stimuli. This is 'demand-driven R&D'. Innovation can also be in stand-alone...
Persistent link: https://www.econbiz.de/10010856305